Background/Aims: This study examined the spectral characteristics of American English vowels in dysarthria associated with cerebral palsy (CP), and investigated the relationship between a speaker’s overall speech intelligibility and vowel contrast. Methods: The data were collected from 12 American English native speakers (9 speakers with a diagnosis of CP and 3 controls). Primary measures were F1 and F2 frequencies of 3 corner vowels /i, a, u/ and 3 noncorner vowels /I, 3, */. Six acoustic variables were derived from the formant measures, and were regressed against intelligibility: corner vowel space, noncorner vowel space, mean distance between vowels, F1 and F2 variability, and overlap degree among vowels. Results: First, the effect of vowel was significant for both F1 and F2 measures for all speakers, but post hoc analysis revealed a reduced distinction at lower intelligibility. Second, regression functions relating intelligibility and acoustic variables were significant for overlap degree among vowels, F1 variability, corner vowel space and mean distance between vowels. Overlap degree among vowels accounted for the greatest amount of variance in intelligibility scores. Conclusion: A speaker’s overall intelligibility in dysarthric speech is better represented by the overlap degree among vowels than by the vowel space.

Keywords:
Dysarthria, Vowel contrast, Speech intelligibility
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.